Home
Cancer types
Treatments
Support
News
Centres and oncologists
Search
Friday, November 13, 2026
Ogkologos.com
Home
Cancer types
Treatments
Support
News
Centres and oncologists
Home
World News
Page 209
World News
World News
ΕΠΙΣΤΗΜΟΝΙΚΑ ΝΕΑ
ΖΩΝΤΑΣ ΜΕ ΚΑΡΚΙΝΟ
ΚΑΡΚΙΝΟΣ
ΚΕΝΤΡΑ ΚΑΡΚΙΝΟΥ – ΟΓΚΟΛΟΓΟΙ
Myths and Facts
ΝΕΑ - ΤΥΠΟΙ ΚΑΡΚΙΝΟΥ
ΤΥΠΟΙ ΚΑΡΚΙΝΟΥ
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
The US National COVID Cohort Collaborative Consortium Provides Real-World Evidence on...
Ogkologos
-
March 29, 2022
0
Genetic Mechanisms Identified for Acquired Resistance to Non-Covalent BTK Inhibitors
Ogkologos
-
March 28, 2022
0
Darolutamide Extends Survival for Some People with Metastatic Prostate Cancer
Ogkologos
-
March 25, 2022
0
FDA Approves Ciltacabtagene Autoleucel for Relapsed or Refractory Multiple Myeloma
Ogkologos
-
March 25, 2022
0
Five Questions with…Jennifer.
Ogkologos
-
March 24, 2022
0
When Cancer Isn’t Your Only Challenge: How I Learned to Cope
Ogkologos
-
March 24, 2022
0
EMA Recommends Granting a Marketing Authorisation for Relugolix
Ogkologos
-
March 24, 2022
0
Latest episode of our podcast for cancer researchers
Ogkologos
-
March 23, 2022
0
Breaking News: Medical Debt and Your Credit Report
Ogkologos
-
March 23, 2022
0
Real-World Increase in Biomarker Testing in Lung Cancer Patients, Registry Study...
Ogkologos
-
March 23, 2022
0
1
...
208
209
210
...
432
Page 209 of 432
MOST POPULAR
EMA Recommends Granting a Marketing Authorisation for Belantamab Mafodotin
August 18, 2025
“If there is an under-representation of ethnic minority communities, there will...
September 18, 2020
FDA Approves Belzutifan for Advanced Renal Cell Carcinoma
January 19, 2024
EMA Recommends Granting a Conditional Marketing Authorisation for Repotrectinib
November 27, 2024
Load more
HOT NEWS
NCI-MATCH Update: More Labs, New Arms, and Initial Findings
¿Comer alimentos a la parrilla o asados puede provocar cáncer?
Some Women Avoid Breast Cancer Screening After False-Positive Mammogram Results
More Evidence that Ruxolitinib Benefits Some Patients with Graft-Versus-Host Disease
Ελληνικά
English (UK)